Abiopharma

🔍 Curley Stephen Russell (Director)

Company: EAGLE BANCORP INC (EGBN)

Report Date: 2026-08-10

Detailed Transactions and Holdings:

• Acquired 8,683 shares of Common Stock (Direct)
  Date: 2026-08-10 | Code: A | equity_swap_involved: 0 | shares_owned_after: 8,683.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 41,606 shares of Common Stock (Direct)
  Date: 2026-08-10 | Code: A | equity_swap_involved: 0 | shares_owned_after: 50,289.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 17,045 shares of Employee Stock Option - Right to Buy at $27.64 per share (Derivative)
  Date: 2026-08-10 | Code: A | Expires: 2036-08-10 | equity_swap_involved: 0 | shares_owned_after: 17,045.00 | transaction_form_type: 4 | Footnotes: F3
• Acquired 59,565 shares of Employee Stock Option - Right to Buy at $27.64 per share (Derivative)
  Date: 2026-08-10 | Code: A | Expires: 2036-08-10 | equity_swap_involved: 0 | shares_owned_after: 59,565.00 | transaction_form_type: 4 | Footnotes: F4

Footnotes:

• F1: Represents an award of 8,683 time-vested restricted stock units granted as part of the Reporting Person's sign-on equity awards (the "Inducement Awards"). The Inducement Awards were issued as inducement grants under Nasdaq listing rules and are subject to the Eagle Bancorp, Inc. 2025 Equity Incentive Plan (the "Plan") as though granted thereunder, except as otherwise provided in the applicable award agreement. The award vests in three substantially equal annual installments commencing on the first anniversary of the date of grant.
• F2: Represents an award of 41,606 time-vested restricted stock units granted as part of the Reporting Person's make-whole equity awards (the "Make Whole Awards"). The Make Whole Awards were issued as inducement grants under Nasdaq listing rules and are subject to the Plan as though granted thereunder, except as otherwise provided in the applicable award agreement. The award vests in four substantially equal annual installments commencing on the first anniversary of the date of grant.
• F3: Represents an award of 17,045 non-qualified stock options granted as part of the Reporting Person's Inducement Awards to purchase common stock at an exercise price of $27.64 per share. The options are scheduled to vest in three equal annual installments beginning on August 10, 2027.
• F4: Represents an award of 59,565 non-qualified stock options granted as part of the Reporting Person's Make Whole Awards to purchase common stock at an exercise price of $27.64 per share. The options are scheduled to vest in four equal annual installments beginning on August 10, 2027.